Activities of Antibiotic Combinations against Resistant Strains of Pseudomonas aeruginosa in a Model of Infected THP-1 Monocytes

Mechanisms of phagocytosis and host clearance of Pseudomonas aeruginosa

(2014) Rustin R. Lovewell et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Pharmacodynamic Evaluation of the Intracellular Activity of Antibiotics towards Pseudomonas aeruginosa PAO1 in a Model of THP-1 Human Monocytes

(2013) Julien M. Buyck et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In VitroSynergy of Colistin Combinations against Colistin-Resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae Isolates

(2012) Céline Vidaillac et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Combination Therapy for Treatment of Infections with Gram-Negative Bacteria

(2012) P. D. Tamma et al.   CLINICAL MICROBIOLOGY REVIEWS

In vitro Etest synergy of doripenem with amikacin, colistin, and levofloxacin against Pseudomonas aeruginosa with defined carbapenem resistance mechanisms as determined by the Etest method

(2012) Wendy He et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Clinically Relevant Plasma Concentrations of Colistin in Combination with Imipenem Enhance Pharmacodynamic Activity against Multidrug-Resistant Pseudomonas aeruginosa at Multiple Inocula

(2011) Phillip J. Bergen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Synergistic Killing of Multidrug-Resistant Pseudomonas aeruginosa at Multiple Inocula by Colistin Combined with Doripenem in an In Vitro Pharmacokinetic/Pharmacodynamic Model

(2011) Phillip J. Bergen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pneumonia Due to Pseudomonas aeruginosa

(2011) Hsin-Yun Sun et al.   CHEST

Cellular accumulation of fluoroquinolones is not predictive of their intracellular activity: studies with gemifloxacin, moxifloxacin and ciprofloxacin in a pharmacokinetic/pharmacodynamic model of uninfected and infected macrophages

(2011) Coralie M. Vallet et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

In vitro activities of ceftobiprole combined with amikacin or levofloxacin against Pseudomonas aeruginosa: evidence of a synergistic effect using time–kill methodology

(2011) Michael Kresken et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Monotherapy or Combination Therapy? ThePseudomonas aeruginosaConundrum

(2011) Kristi A Traugott et al.   PHARMACOTHERAPY

Combination Antibiotic Therapy for Empiric and Definitive Treatment of Gram-Negative Infections: Insights from the Society of Infectious Diseases Pharmacists

(2011) Natalie Boyd et al.   PHARMACOTHERAPY

Subversion of Mucosal Barrier Polarity by Pseudomonas Aeruginosa

(2011) Joanne Engel et al.   Frontiers in Microbiology

Potent Synergy and Sustained Bactericidal Activity of a Vancomycin-Colistin Combination versus Multidrug-Resistant Strains of Acinetobacter baumannii

(2010) N. C. Gordon et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Bacterial distribution in lung parenchyma early after pulmonary infection with Pseudomonas aeruginosa

(2010) Andreas Schmiedl et al.   CELL AND TISSUE RESEARCH

Intracellular Activity of Antibiotics in a Model of Human THP-1 Macrophages Infected by a Staphylococcus aureus Small-Colony Variant Strain Isolated from a Cystic Fibrosis Patient: Study of Antibiotic Combinations

(2009) H. A. Nguyen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY